Literature DB >> 3899670

Haemodynamic effects of indenolol at rest and after a submaximal workload in essential hypertension.

C Aiello, G Groothold, S Gualtieri, L Irace, I L Marini, B Perna, A Romano.   

Abstract

The effect of indenolol on heart rate and blood pressure at rest and after submaximal workload has been studied in 19 patients with established essential hypertension. A stepwise increase from moderate to submaximal exercise was chosen to mimic challenges normally occurring in daily life. After 4 weeks of once a day indenolol therapy a significant, gradual reduction in the following cardiovascular parameters was observed: heart rate at rest fell by 20%, 30% after exercise and 31% after recovery; systolic blood pressure showed a fall of 15% at rest, 19% after workload and 14% after recovery; the reduction in diastolic blood pressure was 15% at rest, 11% after exercise and 12% after recovery. The rate-pressure product was decreased by 32% at rest, 43% after exercise and 42% after recovery. It is concluded that the most important pharmacological effect of indenolol is the significant decrease in myocardial oxygen demand. In patients with essential hypertension indenolol not only produces a definite antihypertensive effect, but it also increases workload tolerance and decreases subjective symptoms during physical activity. Compliance was good and no severe side effects were observed.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3899670     DOI: 10.1007/bf00544058

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  5 in total

1.  Comparison of new -andrenergic blockers, C-3, Kö1366, Y-6124 and YB-2, with pindolol and propranolol in the blood perfused canine papillary muscle preparation.

Authors:  T Kimura; M Endoh; N Taira; K Hashimoto
Journal:  Experientia       Date:  1972-07-15

2.  -adrenergic blocking and cardiovascular properties of a new compound, 1-(7-indenyloxy)-3-isopropylaminopropan-2-ol-hydrochloride (YB-2).

Authors:  T Tanenaka; S Tachikawa
Journal:  Arzneimittelforschung       Date:  1972-11

3.  Comparison of -adrenergic blocking activity of eight blockers in the excised and blood-perfused canine sino-atrial node preparation.

Authors:  K Hashimoto; K Kubota; S Chiba; N Taira
Journal:  Experientia       Date:  1972-07-15

4.  Computerized echocardiographic study of left ventricular function and cardiodynamic investigation with a new antihypertensive agent (indenolol).

Authors:  A Venco; G Groothold; A Grandi; F Barzizza; L Corradi; F Negri; G Finardi
Journal:  Clin Ther       Date:  1985       Impact factor: 3.393

5.  Indenolol in hypertension.

Authors:  R Sega; F Mailland; E Damiani; G Groothold; A Libretti
Journal:  Clin Pharmacol Ther       Date:  1983-03       Impact factor: 6.875

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.